RIPK1 and myocardial ischemia: There exists a positive feedback and regulatory relationship between RIPK1 and PGAM5, suggesting that PGAM5 may serve as a novel therapeutic target for the prevention of myocardial ischemia-reperfusion (I/R) injury63.